Infiltrating CD4/CD8 high T cells shows good prognostic impact in pancreatic cancer

被引:0
作者
Wang, Zhenxia [1 ]
Zhao, Jianguo [1 ]
Zhao, Haiping [1 ]
Sileng, A. [1 ]
Liu, Zhonghua [1 ]
Zhang, Yanfei [1 ]
Liu, Xitao [1 ]
Wang, Fei [1 ]
机构
[1] Inner Mongolia Med Coll Affiliated Hosp, Dept Gen Surg, 1 Tongdao North St, Hohhot 010050, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2017年 / 10卷 / 08期
基金
中国国家自然科学基金;
关键词
Pancreatic cancer; tumor infiltrating lymphocytes; marker; IMMUNE CELLS; CD4(+); MICROENVIRONMENT; IMPROVE; ROLES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor infiltrating lymphocytes in a certain tumor microenvironment are associated with the prognosis of cancer patients. The function of CD4(+) and CD8(+) T cells in the microenvironment of pancreatic cancer remains largely unknown. This study aimed to investigate the prognostic value of both CD4(+) and CD8(+) TIL subsets and their combined role in pancreatic cancer. In this study, pancreatic cancer tissues and corresponding adjacent normal tissues were collected from 90 patients. The expression levels of CD4 and CD8(+) T cells in pancreatic cancer tissues were detected by immunohistochemistry method. The results showed that CD4(+) iTIL expression was significantly correlated with tumor stage. CD8(+) iTILs were significantly correlated with lymphatic vessel invasion and tumor stage; CD8(+) sTILs not only showed correlation with lymphatic vessel invasion and tumor stage, but also had correlation with pathologic differentiation; the survival time of high CD4 expression group was longer compared to the low CD4 expression group. CD4(+) T cells were capable of killing tumor cells and prolonging the survival time of patients either directly or indirectly. According to Cox regression analysis, it was indicated that pathological differentiation, lymphatic vessel invasion, tumor stage, CD4(+) and CD8(+) TILs were the principle risk factors of pancreatic cancer prognosis. Especially multivariate analysis showed that pathological differentiation and the combination of CD4(+) and CD8(+) TILs expression were independent predictors of pancreatic cancer survival. Expression levels of CD4(+) and CD8(+) TILs in pancreatic cancer may provide promising and useful markers for prognosis of pancreatic cancer.
引用
收藏
页码:8820 / 8828
页数:9
相关论文
共 50 条
  • [31] CD4/CD8 Ratio and Cancer Risk among Adults with HIV
    Castilho, Jessica L.
    Bian, Aihua
    Jenkins, Cathy A.
    Shepherd, Bryan E.
    Sigel, Keith
    Gill, M. John
    Kitahata, Mari M.
    Silverberg, Michael J.
    Mayor, Angel M.
    Coburn, Sally B.
    Wiley, Dorothy
    Achenbach, Chad J.
    Marconi, Vincent C.
    Bosch, Ronald J.
    Horberg, Michael A.
    Rabkin, Charles S.
    Napravnik, Sonia
    Novak, Richard M.
    Mathews, W. Christopher
    Thorne, Jennifer E.
    Sun, Jing
    Althoff, Keri N.
    Moore, Richard D.
    Sterling, Timothy R.
    Sudenga, Staci L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (06): : 854 - 862
  • [32] Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer
    Katsuhito Teramatsu
    Takamasa Oono
    Koki Oyama
    Nao Fujimori
    Masatoshi Murakami
    Sho Yasumori
    Akihisa Ohno
    Kazuhide Matsumoto
    Ayumu Takeno
    Kohei Nakata
    Masafumi Nakamura
    Yoshihiro Ogawa
    BMC Cancer, 22
  • [33] Structural and biophysical insights into the role of CD4 and CD8 in T cell activation
    Li, Yili
    Yin, Yiyuan
    Mariuzza, Roy A.
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [34] Rat pancreatic islet and skin xenograft survival in CD4 and CD8 knockout mice
    Krieger, NR
    Ito, H
    Fathman, CG
    JOURNAL OF AUTOIMMUNITY, 1997, 10 (03) : 309 - 315
  • [35] Specific immune recognition of pancreatic carcinoma by patient-derived CD4 and CD8 T cells and its improvement by interferon-γ
    Schmitz-Winnenthal, F. H.
    Escobedo, L. V. Galindo
    Beckhove, P.
    Schirrmacher, V.
    Bucur, M.
    Ziouta, Y.
    Volk, C.
    Schmied, B.
    Koch, M.
    Antolovic, D.
    Weitz, J.
    Buechler, M. W.
    Z'Graggen, K.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (06) : 1419 - 1428
  • [36] Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma
    Hoesli, Rebecca
    Birkeland, Andrew C.
    Rosko, Andrew J.
    Issa, Mohamad
    Chow, Kelsey L.
    Michmerhuizen, Nicole L.
    Mann, Jacqueline E.
    Chinn, Steven B.
    Shuman, Andrew G.
    Prince, Mark E.
    Wolf, Gregory T.
    Bradford, Carol R.
    McHugh, Jonathan B.
    Brenner, J. Chad
    Spector, Matthew E.
    ORAL ONCOLOGY, 2018, 77 : 83 - 89
  • [37] A Novel Prognostic Score Including the CD4/CD8 for AIDS-Related Lymphoma
    Chen, Juanjuan
    Liu, Xuewu
    Qin, Shanfang
    Ruan, Guangjing
    Lu, Aili
    Zhang, Jinxin
    Wu, Yihua
    Xie, Zhiman
    Peng, Jie
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [38] CD4/CD8 lineage commitment: Back to instruction?
    vonBoehmer, H
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) : 713 - 715
  • [39] Characterization of CD4 and CD8 T cells producing IFN-γ in human latent and active tuberculosis
    Rueda, Cesar M.
    Marin, Nancy D.
    Garcia, Luis F.
    Rojas, Mauricio
    TUBERCULOSIS, 2010, 90 (06) : 346 - 353
  • [40] Differences in the Course of CD4 and CD8 Cells After Chemoradiotherapy in People Living with HIV with Anal Cancer
    Schuettfort, Gundolf
    Roether, Caroline
    Berger, Annemarie
    Fokas, Emmanouil
    Fraunholz, Ingeborg
    Groh, Ana
    Haberl, Annette
    Khaykin, Pavel
    Martin, Daniel
    Roedel, Claus
    Vehreschild, Maria
    Stephan, Christoph
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2024, 40 (04) : 198 - 203